Influence of Feiluotong Mistura on Pathomorphological Changes and Fibronectin Content in Rats with Pulmonic Fibrosis

WANG Bin-sheng; LIU Meng-an

您当前的位置：

首页 >

文章列表页 >

Influence of Feiluotong Mistura on Pathomorphological Changes and Fibronectin Content in Rats with Pulmonic Fibrosis

更新时间：2024-01-04

- Influence of Feiluotong Mistura on Pathomorphological Changes and Fibronectin Content in Rats with Pulmonic Fibrosis
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 17, Issue 16, Pages: 195-198(2011)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2011
- 稿件说明：
移动端阅览
WANG Bin-sheng, LIU Meng-an. Influence of Feiluotong Mistura on Pathomorphological Changes and Fibronectin Content in Rats with Pulmonic Fibrosis[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(16): 195-198.
DOI：

WANG Bin-sheng, LIU Meng-an. Influence of Feiluotong Mistura on Pathomorphological Changes and Fibronectin Content in Rats with Pulmonic Fibrosis[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(16): 195-198. DOI：

摘要

目的: 探讨肺络通合剂对肺纤维化大鼠肺组织病理形态学的影响。方法: 选择Wistar大白鼠

气管内注入博莱霉素建立肺纤维化模型。随机分为正常对照组、模型组、中药高、低剂量组和强的松组。除正常对照组外

其余4组均制成肺纤维化动物模型

模型组用生理盐水ig

中药高、低剂量组用肺络通合剂(相当于生药18

9 g·kg-1)ig。强的松组用强的松(2.04 mg·kg-1)ig。各组于用药后28

56 d各随机处死一半大鼠取材送检

观察肺泡炎症病理变化

肺纤维化病理变化和纤维连接蛋白(FN)含量。结果: 模型组大量胶原纤维增生

呈重度肺纤维化改变

平均病理积分(56 d

下同)为2.50±0.71;肺络通合剂高剂量组呈轻度肺纤维化(1.00±0.82);低剂量组(1.50±0.85)病变程度较中药高剂量组略重

强的松组(1.80±0.92)病变程度较模型组轻

但较中药高剂量组为重;FN含量平均A值(28 d)肺络通高剂量组(49.55±6.57)明显低于模型组(272.11±40.12)

且作用优于强的松组(73.25±11.11)。结论: 肺络通合剂能有效抑制博莱霉素引起的肺纤维化形成。

Abstract

Objective: To observe the Pathomorphological changes in rats with pulmonic fibrosis treating by Feiluotong Mistura. Method: Wistar rats were divided into normal group

model group

herbal therapy high dose group

herbal therapy low dose group

western medicine (WM) group. In addition to the normal group

the other four groups were reproduced animal model of pulmonic fibrosis. The model group were given normal saline gavage. The herbal therapy high dose group was given Feiluotong Mistura (18 g·kg-1) gavage. The herbal therapy low dose group was given Feiluotong Mistura (9.0 g·kg-1) gavage. WM group given prednisone gavage. Half of each group were taken lung to test in the 28th day and the 56th day. Result: Large collagen fibers hyperplasia was founded in the model group

a severe pulmonary fibrosis in WM group. Mild pulmonary fibrosis was founded in the herbal therapy high dose group

fibrosis in the herbal therapy low dose group was more severe than that in the herbal therapy high dose group

Lesions of WM group were milder than that of the model group. Conclusion: Feiluotong Mistura can effectively inhibit the formation of pulmonary fibrosis induced by bleocin.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Hei Xiaoyaosan on Neuroinflammation and NLRP3/Caspase-1/GSDMD Signaling Pathway in APP/PS1 Mice

Effect of Longmu Piyan Prescription on Oxidative Stress in Atopic Dermatitis Mice

Traditional Chinese Medicine in Treatment of Ulcerative Colitis Based on NLRP3 Inflammasome： A Review

Effect of Tripterygium wilfordii Polyglycoside on Expression of NFAT2/COX-2 in Kidney Tissues of Rats with Diabetic Nephropathy

Mechanism of Danggui Shanyaosan in Alzheimer's Disease： A Review

Related Author

ZHOU Jun

LI Mingcheng

LYU Yujie

MENG Zhipeng

HU Yunyun

WANG Huping

MA Mengxi

WU Siqi

Related Institution

Guizhou Health Vocational College

Zhengzhou TCM Hospital Affiliated to Henan University of Chinese Medicine

Xingtai Hospital of TCM

Qujing 69 Hospital，China RongTong Medical Healthcare Group Co.， Ltd.

Xichang Hospital of TCM，Xichang

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰